On December 21, 2023, Atrion Corporation (the ?Company?), as borrower, entered into an Amended and Restated Credit Agreement (the ?Credit Agreement?) with Wells Fargo Bank, National Association (?Wells Fargo?), as lender. The Credit Agreement provides for a $25.0 million revolving credit facility, with an uncommitted feature allowing for the Company to request increases to the revolving credit commitment of up to $50.0 million in the aggregate. The indebtedness outstanding under the Credit Facility will be evidenced by an Amended and Restated Revolving Credit Note dated December 21, 2023.

The Credit Agreement amends and restates that certain existing Credit Agreement dated as of February 28, 2017, as amended by that certain First Amendment to Credit Agreement dated as of February 12, 2021 and by that certain Second Amendment to Credit Agreement dated as of June 29, 2023 between the Company and Wells Fargo (the ?Existing Credit Agreement?). The Credit Agreement will mature on December 21, 2026. Borrowings under the Credit Agreement will bear interest at a rate per annum equal to an agreed applicable margin plus, at Company's election, a prime rate equivalent equal to the ?Base Rate,?

a rate based on the ?Adjusted Daily Simple SOFR,? or on the ?Adjusted Term SOFR? as those terms are defined in the Credit Agreement.

For borrowings that bear interest at the Base Rate, the applicable margin ranges from 0% to 0.75%. For borrowings that bear interest at Adjusted Daily Simple SOFR or at Adjusted Term SOFR, the applicable margin ranges from 1.00% to 1.75%. The Credit Agreement also provides for a commitment fee applicable to the unused portion of the revolving credit facility ranging from 0.30% to 0.45% per annum, payable in arrears on the last business day of each calendar quarter.

The payment and performance of the obligations under the Credit Agreement are guaranteed by the Company?s subsidiaries, Atrion Medical Products Inc., Halkey-Roberts Corporation, Quest Medical Inc., Atrion Leasing Company, LLC, and AlaTenn Pipeline Company, LLC (collectively, the ?Subsidiaries?), each of which has executed and delivered a Guaranty Agreement with Wells Fargo, dated as of February 28, 2017 (the ?Guaranty Agreement?). The Credit Agreement contains customary affirmative and negative covenants for credit facilities of this type, including, among other things, a maximum consolidated total leverage ratio, a maximum consolidated senior secured leverage ratio, a minimum consolidated fixed charge coverage ratio, and a minimum consolidated net income as well as limitations on the use of proceeds of revolving credit loans, certain investments and asset dispositions and certain fundamental changes. The Credit Agreement contains customary events of default, subject to certain exceptions and grace periods.